[Hypopituitarism caused by colonic carcinoma metastasis associated with hypophysial aspergillosis]

G Stalldecker1, H A Molina, N Antelo

  • 1Divisione Endocrinología, Hospital J. M. Ramos Mejía, Buenos Aires, Argentina.

Medicina
|January 1, 1994
PubMed

Insights

This case study highlights a rare instance of pituitary metastases from colon cancer complicated by cerebral aspergillosis. The patient presented with hypopituitarism and hyperprolactinemia, demonstrating a complex interplay of neoplastic and infectious processes.

Area of Science:

  • Endocrinology
  • Neurology
  • Oncology

Background:

  • Pituitary metastases are rare, often affecting the posterior lobe and potentially causing diabetes insipidus.
  • Cerebral aspergillosis is an uncommon infection, typically seen in immunocompromised individuals or post-neurosurgery.
  • Colon adenocarcinoma is a common malignancy, but its metastasis to the pituitary gland is infrequent.

Observation:

  • A patient with a history of colon adenocarcinoma presented with hypopituitarism and hyperprolactinemia.
  • Cerebral MRI revealed an intra- and suprasellar mass with hypothalamic extension.
  • Lung and lymph node imaging showed a mass consistent with metastatic disease.

Findings:

  • Microscopic examination of the pituitary mass revealed colon adenocarcinoma metastasis.
  • Evidence of Aspergillus hyphae within the pituitary tumor, forming abscesses, was identified.
  • Laboratory tests indicated deficiencies in ACTH, LH, and FSH, with mild hyperprolactinemia.

Implications:

  • This case underscores the importance of considering unusual metastatic patterns in oncology.
  • The co-occurrence of pituitary metastasis and cerebral aspergillosis presents a diagnostic and therapeutic challenge.
  • This highlights the need for comprehensive evaluation in patients with unexplained pituitary dysfunction and a history of malignancy.

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...